ZIPZOC

This brand name is authorized in Austria, Finland, Ireland, New Zealand.

Active ingredients

The drug ZIPZOC contains one active pharmaceutical ingredient (API):

1	Zinc oxide UNII SOI2LOH54Z - ZINC OXIDE
	Zinc blocks the intestinal absorption of copper from the diet and the reabsorption of endogenously secreted copper. Zinc induces the production of metallothionein in the enterocyte, a protein that binds copper thereby preventing its transfer into the blood. The bound copper is then eliminated in the stool following desquamation of the intestinal cells.
	Read more about Zinc

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ZIPZOC Impregnated dressing	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D09AB01	Zinc bandage without supplements	D Dermatologicals → D09 Medicated dressings → D09A Medicated dressings → D09AB Zinc bandages
Discover more medicines within D09AB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
FI	Lääkealan turvallisuus- ja kehittämiskeskus	561399, 561407
NZ	Medicines and Medical Devices Safety Authority	8040